Windtree Therapeutics Inc WINT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/20/22 EDT
0.60quote price arrow up+0.03 (+5.45%)
Volume
6,416
Close
0.569quote price arrow up+0.029 (+5.37%)
Volume
348,517
52 week range
0.48 - 3.40
Loading...
  • Open0.56
  • Day High0.59
  • Day Low0.54
  • Prev Close0.54
  • 52 Week High3.40
  • 52 Week High Date06/04/21
  • 52 Week Low0.48
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap16.73M
  • Shares Out29.41M
  • 10 Day Average Volume0.28M
  • Dividend-
  • Dividend Yield-
  • Beta0.36
  • YTD % Change-64.55

KEY STATS

  • Open0.56
  • Day High0.59
  • Day Low0.54
  • Prev Close0.54
  • 52 Week High3.40
  • 52 Week High Date06/04/21
  • 52 Week Low0.48
  • 52 Week Low Date05/12/22
  • Market Cap16.73M
  • Shares Out29.41M
  • 10 Day Average Volume0.28M
  • Dividend-
  • Dividend Yield-
  • Beta0.36
  • YTD % Change-64.55

RATIOS/PROFITABILITY

  • EPS (TTM)-2.48
  • P/E (TTM)-0.23
  • Fwd P/E (NTM)-0.75
  • EBITDA (TTM)-30.893M
  • ROE (TTM)-105.85%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)39.42%
  • Net Margin (TTM)-17,387.34%
  • Debt To Equity (MRQ)43.19%

EVENTS

  • Earnings Date08/03/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Windtree Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is focused on the development of therapeutics intended to address significant unmet medical needs. The Company’s development programs are primarily focused on the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. Its Cardiovascular Program’s products candidates include Istaroxime, Oral SERCA2a Activators and Rostafuroxin. Its Pulmonary Program’s product candidates...
James Huang
Independent Chairman of the Board
Craig Fraser
President, Chief Executive Officer, Director
Eric Curtis
Chief Operating Officer, Senior Vice President
John Hamill CPA
Chief Financial Officer, Senior Vice President, Corporate Secretary
Joseph Soffer M.D.
Executive Vice President - Clinical Development
Randall White Ph.D.
Vice President - Clinical Program Management
Address
2600 Kelly Rd Ste 100
Warrington, PA
18976-3652
United States

Top Peers

SYMBOLLASTCHG%CHG
DFFN
Diffusion Pharmaceuticals Inc
7.81UNCHUNCH
GLMD
Galmed Pharmaceuticals Ltd
0.559+0.0588+11.76%
NNVC
NanoViricides Inc
2.60+0.75+40.54%
NERV
Minerva Neurosciences Inc
0.3721-0.019-4.8581%
TENX
Tenax Therapeutics Inc
0.636-0.0438-6.4431%